SCHEMBL4100134

SCHEMBL4100134

N=C(N)N/N=C/c1ccccn1

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.59
RAB9A P51151 5/20 0.59
LMNA P02545 3/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
TOP2A P11388 2/20 0.59
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
CTH P32929 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
HTT P42858 3/20 0.55
ALDH1A1 P00352 3/20 0.55
KDM4E B2RXH2 3/20 0.55
MAPT P10636 2/20 0.55
OPRK1 P41145 2/20 0.55
ADORA2A P29274 1/20 0.55
AGTR1 P30556 2/20 0.54
CYP1A2 P05177 1/20 0.52
HKDC1 Q2TB90 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4100136 1.00 NPC1 (0.59) NPC1RAB9ALMNASMN1; SMN2TOP2A
SCHEMBL9458210 0.86 NPC1 (0.62) NPC1RAB9ALMNASMN1; SMN2TOP2A
Hydrochloric Acid SCHEMBL32681298 0.85 NPC1 (0.60) NPC1RAB9ALMNASMN1; SMN2TOP2A
SCHEMBL534248 0.83 TOP2A (0.68) NPC1RAB9ALMNASMN1; SMN2TOP2A
SCHEMBL14542967 0.83 NPC1 (0.59) NPC1RAB9ALMNASMN1; SMN2TOP2A
SCHEMBL13826730 0.83 NPC1 (0.68) NPC1RAB9ALMNASMN1; SMN2TOP2A
SCHEMBL293101 0.83 TOP2A (0.68) NPC1RAB9ALMNASMN1; SMN2TOP2A
SCHEMBL20148186 0.81 CTH (0.46) LMNASMN1; SMN2MEN1KMT2ACTH
SCHEMBL31690655 0.79 TOP2A (0.82) NPC1RAB9ALMNASMN1; SMN2TOP2A
Hydrochloric Acid SCHEMBL3054023 0.79 CTH (0.45) LMNASMN1; SMN2MEN1KMT2ACTH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030186993-A1 Anti-malarial compounds, compositions and methods KENNETH S. WARREN INSTITUTE 2003-10-02 US claimed
US-20090194124-A1 Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine MALLE GERARD 2009-08-06 US disclosed
US-20090139537-A1 HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE L'OREAL S.A. 2009-06-04 US disclosed
US-20050136017-A1 Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin L'OREAL S.A. (FR) 2005-06-23 US disclosed
US-20050129645-A1 Hair shaping composition comprising at least one non-hydroxide imine L'OREAL 2005-06-16 US disclosed
EP-1532960-A1 Hair styling composition containing a non-hydroxide imine L'OREAL (FR) 2005-05-25 EP disclosed
US-6689777-B2 DEPOLYMERIZING HEMOZOIN USING 2-IMINO-NAPHTHO(1,2-D)THIAZOL-5-OL DERIVATIVES KENNETH S. WARREN INSTITUTE 2004-02-10 US disclosed
US-20030186993-A1 Anti-malarial compounds, compositions and methods KENNETH S. WARREN INSTITUTE 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090139537-A1 HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE KRT18, INMT, INHA NPC1 4841/4885RAB9A 2870/4885LMNA 117/4885
US-20090194124-A1 Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine KRT18, KIT, PRDM7 NPC1 4782/4885RAB9A 1539/4885LMNA 132/4885
US-20030186993-A1 Anti-malarial compounds, compositions and methods TYR, CRYZ, RHOT2 NPC1 405/4885RAB9A 2037/4885LMNA 448/4885
US-20050129645-A1 Hair shaping composition comprising at least one non-hydroxide imine KRT18, INHA, H1-5 NPC1 4747/4885RAB9A 2224/4885LMNA 85/4885
US-20050136017-A1 Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin BHMT, KRT18, INMT NPC1 4179/4885RAB9A 1450/4885LMNA 129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.